Point-of-care UTI test with antimicrobial susceptibility in under an hour
Diagnose uncomplicated UTIs at point of care; Prevent misprescribed antibiotics; Reduce patient wait times from days to under an hour; Provide antimicrobial susceptibility data to guide treatment; Counter antimicrobial resistance by enabling accurate treatment decisions
Secured £3.2M seed funding in March 2024; Longlisted for Nature Spinoff Award; Finalist for Healthtech Challenger Award; Supported by Innovate UK and Texas Medical Center Innovation Accelerator; Participated in Innovate UK Global Incubator Program with Texas Medical Center Innovation